Who are Particella's investors?

Particella's investors include SOSV, IndieBio.

When was Particella founded?

Particella was founded in 2016.

Where is Particella headquartered?

Particella is headquartered in San Francisco, California, United States.

What industry is Particella in?

Particella operates in Biotech, Drug Discovery & Delivery.

Particella

Oral mRNA Medicines

San Francisco, United States · Founded 2016

Biotech

Drug Discovery & Delivery

Headquarters: San Francisco, California
Employees: 1–10
Founded: 2016
Business Model: B2B

Website: particella.bio
Last Round: Convertible NoteMar 2023
Rounds: 2

About

Particella (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing oral lipid nanoparticle technology to deliver nucleic acids to the intestinal epithelium. Its platform enables oral mRNA medicines with repeatable dosing that are non-immunogenic and patient-friendly, targeting a major unmet need in gene therapy drug delivery.

Summary

Particella is a Biotech company based in San Francisco, United States, founded in 2016. Its most recent funding was a Convertible Note round in Mar 2023. Investors include SOSV and IndieBio.